← 產業報告目錄

ECMO Machines Market by Product [ECMO Machines, Components (Oxygenators, Pumps, Controllers)], Modality (Venovenous and Arteriovenous ECMO), Patient Type (Adults, Neonates), Application (Respiratory, Cardiac), End User (Hospitals) - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Medical Devices出版日期 2025-10-09頁數 252報告編號 MD3966

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The ECMO machines market is projected to reach USD 0.86 billion by 2030 from USD 0.65 billion in 2025, at a CAGR of 5.8% during the forecast period. In recent years, ECMO machines have evolved from bulky, manual-intensive systems to compact, automated, and highly efficient platforms. Next-generation ECMO integrates real-time monitoring, automated flow adjustments, and artificial intelligence (AI)-driven oxygenation control to reduce the need for constant manual intervention. Companies such as Getinge AB and Medtronic are leading in portable ECMO innovations, enabling smoother inter-hospital and intra-hospital patient transfers. Some systems now feature wireless connectivity and cloud-based monitoring, allowing specialists to track remote patient data. Improved centrifugal pumps and polymethyl pentene (PMP) oxygenators enhance durability and reduce complications such as hemolysis or clot formation. Moreover, innovations in anticoagulation management reduce the risks of bleeding, a historical challenge for ECMO patients. These technological leaps improve patient survival and make ECMO more user-friendly for hospitals with limited staff, driving wider adoption across developed and emerging healthcare markets. Based on product, the market of ECMO machines is divided into components and ECMO machines. In 2024, the components segment held the largest share of the global ECMO machines market. With the rising incidence of acute respiratory distress syndrome (ARDS), cardiac arrest, and multi-organ failure, ECMO usage has expanded globally across tertiary hospitals. Each ECMO procedure consumes oxygenators, pumps, tubing sets, controllers, and cannulas. Even in short-term ECMO, components like oxygenators and cannulas are single-use, while pumps require precise compatibility and often get upgraded with each procedure. Post-pandemic preparedness further contributes to higher ECMO use, ensuring steady turnover of components. Unlike the machine itself, which remains constant, the increasing number of procedures fuels exponential growth in the component segment. Based on patient type, the ECMO market has been categorized into adults, pediatrics and neonates. In 2024, adults held the largest market share in the ECMO machines market. The COVID-19 pandemic highlighted ECMO’s role in treating severe respiratory failure in adults. During the peak, most ECMO-supported cases were adults with severe ARDS. Even after the acute pandemic phase, many survivors experienced long-term pulmonary damage, fibrosis, and other respiratory complications that increased ECMO utilization in critical cases. Post-COVID-19 complications like myocarditis and post-viral pneumonia also primarily affect adults, contributing to higher demand for ECMO in this age group. Hospitals worldwide expanded ECMO infrastructure during the pandemic, with a focus on adult ICUs, leaving a long-term impact on equipment adoption. This legacy effect ensured that adults continued to account for the largest ECMO market share in 2024. North America is expected to account for the largest share of the ECMO machines market during the forecast period. North America, particularly the US and Canada, benefits from a highly advanced healthcare ecosystem equipped with top-tier hospitals, critical care units, and specialized medical centers. These facilities can support sophisticated and resource-intensive technologies such as ECMO. Large tertiary hospitals and academic medical centers often serve as hubs for ECMO procedures, offering advanced ICUs and trained multidisciplinary teams that ensure effective patient management. In contrast to emerging regions, North American hospitals possess the financial and infrastructural capacity to invest in expensive ECMO equipment and maintain it efficiently. Furthermore, strong integration of digital health systems, including advanced monitoring tools, ensures safe ECMO management. This infrastructure readiness makes it feasible for ECMO adoption at scale, enhancing accessibility and increasing survival outcomes. As a result, the well-developed healthcare network plays a central role in reinforcing North America’s leadership in the ECMO machines market. A breakdown of the primary participants (supply-side) for the ECMO machines market referred to in this report is provided below: • By Company Type: Tier 1: 34%, Tier 2: 38%, and Tier 3: 28% • By Designation: C Level: 26%, Director Level: 35%, and Others: 39% • By Region: North America: 17%, Europe: 39%, Asia Pacific: 28%, Latin America: 8%, Middle East & Africa: 3%, GCC Countries: 5% Prominent players in the ECMO machines market are Fresenius Medical Care AG & Co. KGaA (Germany), Getinge AB (Sweden), Medtronic (Ireland), Terumo Corporation (Japan), and LivaNova PLC (UK). Research Coverage The report evaluates the ECMO machines market and estimates the market size and future growth potential based on various segments, including product, modality, patient type, application, end user, and region. The report also includes a competitive analysis of the major players in this market, along with company profiles, product offerings, recent developments, and key market strategies. Reasons to Buy the Report The report will assist the market leader/new entrants with data on the nearest approximations of the revenue numbers for the overall ECMO machines market and the subsegments. The report will assist stakeholders in understanding the competitive landscape and gain further insights into better positioning their businesses and making appropriate go-to-market strategies. The report assists the stakeholders in understanding the market pulse and gives them data on influential drivers, hindrances, obstacles, and opportunities in the market. This report provides insights into the following points:  Analysis of key drivers (Increasing prevalence of cardiovascular and respiratory diseases, Growing adoption of ECMO in lung transplantation procedures), restraints (Complications associated with ECMO, High cost of ECMO procedures), opportunities (Increasing survival rates with ECMO), and challenges (Shortage of skilled professionals, Eligibility issues for ECMO) • Product Launches/Innovations: Comprehensive details about product launches and anticipated trends in the global ECMO machines market • Market Development: Thorough knowledge and analysis of the profitable rising markets by product, modality, patient type, application, end user, and region • Market Diversification: Comprehensive information about newly launched products and services, expanding markets, current advancements, and investments in the global ECMO machines market • Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings, and capacities of the major competitors in the global ECMO machines market
目錄 Table of Contents
1 INTRODUCTION 25 1.1 STUDY OBJECTIVES 25 1.2 MARKET DEFINITION 25 1.3 STUDY SCOPE 26 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE 26 1.3.2 INCLUSIONS AND EXCLUSIONS 27 1.3.3 YEARS CONSIDERED 28 1.4 CURRENCY CONSIDERED 28 1.5 STAKEHOLDERS 29 1.6 SUMMARY OF CHANGES 29 2 RESEARCH METHODOLOGY 31 2.1 RESEARCH DATA 31 2.1.1 SECONDARY DATA 32 2.1.1.1 Key data from secondary sources 33 2.1.2 PRIMARY DATA 33 2.1.2.1 Key data from primary sources 34 2.1.2.2 Key industry insights 35 2.2 MARKET SIZE ESTIMATION 37 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 42 2.4 MARKET SHARE ESTIMATION 43 2.5 RESEARCH ASSUMPTIONS 44 2.6 RESEARCH LIMITATIONS 44 2.7 RISK ASSESSMENT 44 3 EXECUTIVE SUMMARY 45 4 PREMIUM INSIGHTS 49 4.1 ECMO MACHINES MARKET OVERVIEW 49 4.2 ASIA PACIFIC: ECMO MACHINES MARKET, BY PRODUCT AND COUNTRY (2024) 50 4.3 ECMO MACHINES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 51 4.4 ECMO MACHINES MARKET, REGIONAL MIX, 2023−2030 51 4.5 ECMO MACHINES MARKET: EMERGING VS. DEVELOPED ECONOMIES 52 5 MARKET OVERVIEW 53 5.1 INTRODUCTION 53 5.2 MARKET DYNAMICS 53 5.2.1 DRIVERS 54 5.2.1.1 Increasing prevalence of cardiovascular and respiratory diseases 54 5.2.1.2 Growing adoption of ECMO in lung transplantation procedures 55 5.2.1.3 Rise in ECMO centers worldwide 55 5.2.1.4 Technological advancements in ECMO machines 55 5.2.2 RESTRAINTS 56 5.2.2.1 Complications associated with ECMO 56 5.2.2.2 High cost of ECMO procedures 56 5.2.3 OPPORTUNITIES 57 5.2.3.1 Increasing survival rates with ECMO 57 5.2.4 CHALLENGES 57 5.2.4.1 Shortage of skilled professionals 57 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 57 5.4 PRICING ANALYSIS 58 5.4.1 AVERAGE SELLING PRICE OF KEY PLAYERS, BY TYPE 58 5.4.2 AVERAGE SELLING PRICE TREND, BY REGION 59 5.5 VALUE CHAIN ANALYSIS 60 5.6 SUPPLY CHAIN ANALYSIS 62 5.7 ECOSYSTEM ANALYSIS 63 5.8 INVESTMENT AND FUNDING SCENARIO 65 5.9 TECHNOLOGY ANALYSIS 66 5.9.1 KEY TECHNOLOGIES 66 5.9.1.1 Advanced oxygenator design 66 5.9.1.2 High-efficiency blood pumps 67 5.9.2 COMPLEMENTARY TECHNOLOGIES 67 5.9.2.1 Advanced hemodynamic monitoring systems 67 5.9.2.2 Ventilators 67 5.9.3 ADJACENT TECHNOLOGIES 68 5.9.3.1 Wearable Artificial Lungs (WALs) 68 5.9.3.2 Perfusion systems 68 5.10 INDUSTRY TRENDS 69 5.10.1 GROWING ADOPTION OF ECMO IN NON-TRADITIONAL CARE SETTINGS 69 5.10.2 INCREASING USE OF ECMO IN PEDIATRIC AND NEONATAL CARE 69 5.10.3 SHIFT TOWARD ECMO CENTERS OF EXCELLENCE AND REGIONALIZATION 69 5.10.4 GROWTH OF ECMO SIMULATION TRAINING AND TELE-ECMO PROGRAMS 70 5.11 PATENT ANALYSIS 70 5.12 TRADE ANALYSIS 71 5.12.1 IMPORT DATA FOR HS CODE 901890 71 5.12.2 EXPORT DATA FOR HS CODE 901890 72 5.13 KEY CONFERENCES AND EVENTS, 2025–2026 73 5.14 CASE STUDY ANALYSIS 74 5.14.1 CASE STUDY 1: IMPROVED SURVIVAL RATES IN US USING ECMO 74 5.14.2 CASE STUDY 2: NEONATAL ECMO PROGRAM IN UK 74 5.14.3 CASE STUDY 3: MOBILE ECMO TRANSPORT SERVICE IN GERMANY 74 5.15 REGULATORY LANDSCAPE 75 5.15.1 REGULATORY ANALYSIS 75 5.15.1.1 North America 75 5.15.1.1.1 US 75 5.15.1.1.2 Canada 75 5.15.1.2 Europe 75 5.15.1.2.1 Germany 75 5.15.1.2.2 France 76 5.15.1.2.3 UK 76 5.15.1.3 Asia Pacific 76 5.15.1.3.1 China 76 5.15.1.3.2 Japan 77 5.15.1.3.3 India 77 5.15.1.4 Latin America 77 5.15.1.4.1 Brazil 77 5.15.1.4.2 Mexico 78 5.15.1.5 Middle East & Africa 78 5.15.1.5.1 South Africa 78 5.15.1.5.2 GCC Countries 78 5.15.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79 5.16 PORTER’S FIVE FORCES ANALYSIS 81 5.16.1 BARGAINING POWER OF SUPPLIERS 82 5.16.2 BARGAINING POWER OF BUYERS 82 5.16.3 THREAT OF NEW ENTRANTS 82 5.16.4 THREAT OF SUBSTITUTES 83 5.16.5 INTENSITY OF COMPETITIVE RIVALRY 83 5.17 KEY STAKEHOLDERS AND BUYING CRITERIA 83 5.17.1 KEY STAKEHOLDERS IN BUYING PROCESS 83 5.17.2 BUYING CRITERIA 84 5.18 UNMET NEEDS/END-USER EXPECTATIONS 85 5.19 ADJACENT MARKET ANALYSIS 85 5.20 IMPACT OF AI/GEN AI ON ECMO MACHINES MARKET 86 5.20.1 INTRODUCTION 86 5.20.2 MARKET POTENTIAL OF GEN AI ON ECMO MACHINES MARKET 86 5.20.3 AI USE CASES 87 5.20.4 KEY COMPANIES IMPLEMENTING AI 87 5.20.5 FUTURE OF GEN AI IN ECMO MACHINES MARKET 88 5.21 IMPACT OF 2025 US TARIFF ON ECMO MACHINES MARKET 88 5.21.1 KEY TARIFF RATES 89 5.21.2 PRICE IMPACT ANALYSIS 90 5.21.3 KEY IMPACT ON COUNTRY/REGION 90 5.21.3.1 US 90 5.21.3.2 Europe 90 5.21.3.3 Asia Pacific 91 5.21.4 IMPACT ON END-USE INDUSTRIES 91 6 ECMO MACHINES MARKET, BY PRODUCT 92 6.1 INTRODUCTION 93 6.2 COMPONENTS 93 6.2.1 OXYGENATORS 94 6.2.1.1 Significantly less priming volume associated with PMP oxygenators to boost demand 94 6.2.2 PUMPS 96 6.2.2.1 Pivotal role played by centrifugal blood pumps in adult extracorporeal life support to support market growth 96 6.2.3 CONTROLLERS 97 6.2.3.1 Ability of controllers to allow operators of ECMO circuits to adjust settings as needed to drive demand 97 6.2.4 CANNULAS 98 6.2.4.1 Importance of cannulas in optimizing ECMO flows to boost market 98 6.2.5 ACCESSORIES 99 6.3 MACHINES 101 6.3.1 ADVANTAGES SUCH AS TIMELY INTERVENTION IN CASES OF RESPIRATORY AND CARDIAC EMERGENCIES TO FUEL GROWTH 101 7 ECMO MACHINES MARKET, BY MODALITY 103 7.1 INTRODUCTION 104 7.2 VENOVENOUS ECMO 104 7.2.1 LOWER INCIDENCE OF NEUROLOGIC COMPLICATIONS AND LACK OF ARTERIAL COMPROMISE TO BOOST GROWTH 104 7.3 VENOARTERIAL ECMO 105 7.3.1 INCREASING INCIDENCE OF HEART-LUNG FAILURE TO DRIVE GROWTH 105 7.4 ARTERIOVENOUS ECMO 106 7.4.1 PORTABILITY OF ARTERIOVENOUS ECMO MACHINES TO DRIVE DEMAND 106 8 ECMO MACHINES MARKET, BY PATIENT TYPE 108 8.1 INTRODUCTION 109 8.2 ADULT PATIENTS 110 8.2.1 TECHNOLOGICAL ADVANCEMENTS TO DRIVE USE OF ECMO IN ADULT PATIENTS 110 8.3 PEDIATRIC PATIENTS 111 8.3.1 RECENT ADVANCES IN ECMO TO BOOST MARKET GROWTH 111 8.4 NEONATES 112 8.4.1 INCREASING UTILIZATION OF ECMO TO MANAGE NEONATES WITH CARDIAC AND RESPIRATORY FAILURE TO SUPPORT GROWTH 112 9 ECMO MACHINES MARKET, BY APPLICATION 113 9.1 INTRODUCTION 114 9.2 RESPIRATORY APPLICATIONS 114 9.2.1 INCREASING CASES OF ACUTE RESPIRATORY DISTRESS SYNDROME, PNEUMONIA, AND INFLUENZA TO SPUR GROWTH 114 9.3 CARDIAC APPLICATIONS 115 9.3.1 RISING PREVALENCE OF CARDIOVASCULAR DISEASES WORLDWIDE TO SUPPORT GROWTH 115 9.4 EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION 116 9.4.1 GROWING CLINICAL EVIDENCE SUGGESTING IMPROVED SURVIVAL RATES AND NEUROLOGICAL OUTCOMES TO FUEL MARKET 116 10 ECMO MACHINES MARKET, BY END USER 118 10.1 INTRODUCTION 119 10.2 HOSPITALS 119 10.2.1 GROWING USE OF ECMO FOR MANAGING CRITICAL CONDITIONS TO DRIVE MARKET 119 10.3 ACADEMIC & RESEARCH INSTITUTIONS 120 10.3.1 INCREASING MEDICAL COLLEGES AND RESEARCH FACILITIES INVESTING IN ECMO SYSTEMS TO FOSTER GROWTH 120 10.4 SPECIALTY CLINICS 121 10.4.1 RISING NEED FOR ADVANCED, LIFE-SAVING INTERVENTIONS TO AID GROWTH 121 11 ECMO MACHINES MARKET, BY REGION 123 11.1 INTRODUCTION 124 11.2 NORTH AMERICA 124 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 124 11.2.2 US 128 11.2.2.1 US to account for largest share of North American market 128 11.2.3 CANADA 130 11.2.3.1 Implementation of ABF model in Canadian hospitals to drive market growth 130 11.3 EUROPE 133 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 133 11.3.2 GERMANY 135 11.3.2.1 Increasing volume of ECMO procedures to drive market growth in Germany 135 11.3.3 FRANCE 138 11.3.3.1 Rising healthcare spending to drive market growth in France 138 11.3.4 UK 140 11.3.4.1 Significant investment in healthcare to support adoption of advanced medical technologies like ECMO 140 11.3.5 ITALY 143 11.3.5.1 High burden of CVDs to contribute to growth of ECMO machines market in Italy 143 11.3.6 SPAIN 145 11.3.6.1 High adoption of advanced technologies to drive market growth in Spain 145 11.3.7 REST OF EUROPE 148 11.4 ASIA PACIFIC 149 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 150 11.4.2 JAPAN 153 11.4.2.1 Favorable healthcare infrastructure in Japan to drive market growth 153 11.4.3 CHINA 156 11.4.3.1 Large patient population and government-backed critical care infrastructure expansion to fuel growth 156 11.4.4 INDIA 158 11.4.4.1 Growing applications and rising adoption of ECMO to drive market growth in India 158 11.4.5 SOUTH KOREA 161 11.4.5.1 Advanced healthcare infrastructure and early ECMO adoption to position South Korea as leading regional market 161 11.4.6 AUSTRALIA 163 11.4.6.1 Rising respiratory and cardiac complications, coupled with aging population, to fuel ECMO adoption 163 11.4.7 REST OF ASIA PACIFIC 165 11.5 LATIN AMERICA 168 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 168 11.5.2 BRAZIL 171 11.5.2.1 Rising adoption of ECMO as bridge to heart and lung transplantation to drive market growth in Brazil 171 11.5.3 MEXICO 173 11.5.3.1 High burden of CVDs in country to drive market growth in Mexico 173 11.5.4 REST OF LATIN AMERICA 175 11.6 MIDDLE EAST & AFRICA 178 11.6.1 INCREASING PREVALENCE OF TARGET DISEASES TO DRIVE MARKET GROWTH IN MIDDLE EAST & AFRICA 178 11.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 178 11.7 GCC COUNTRIES 180 11.7.1 RISING INVESTMENTS IN ADVANCED HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH 180 11.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES 181 12 COMPETITIVE LANDSCAPE 184 12.1 OVERVIEW 184 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 184 12.3 REVENUE ANALYSIS, 2020–2024 186 12.4 MARKET SHARE ANALYSIS, 2024 187 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 188 12.5.1 STARS 188 12.5.2 EMERGING LEADERS 188 12.5.3 PERVASIVE PLAYERS 189 12.5.4 PARTICIPANTS 189 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 190 12.5.5.1 Company footprint 190 12.5.5.2 Region footprint 191 12.5.5.3 Product footprint 191 12.5.5.4 Application footprint 192 12.5.5.5 End-user footprint 192 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 193 12.6.1 PROGRESSIVE COMPANIES 193 12.6.2 RESPONSIVE COMPANIES 193 12.6.3 DYNAMIC COMPANIES 193 12.6.4 STARTING BLOCKS 193 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 195 12.6.5.1 Detailed list of key startups/SMEs 195 12.6.5.2 Competitive benchmarking of startups/SMEs 195 12.7 COMPANY VALUATION & FINANCIAL METRICS 196 12.7.1 FINANCIAL METRICS 196 12.7.2 COMPANY VALUATION 196 12.8 BRAND/PRODUCT COMPARISON 197 12.9 COMPETITIVE SCENARIO 198 12.9.1 PRODUCT LAUNCHES & APPROVALS 198 12.9.2 DEALS 199 12.9.3 EXPANSIONS 199 13 COMPANY PROFILES 200 13.1 KEY PLAYERS 200 13.1.1 GETINGE 200 13.1.1.1 Business overview 200 13.1.1.2 Products offered 201 13.1.1.3 Recent developments 202 13.1.1.3.1 Product launches 202 13.1.1.3.2 Expansions 202 13.1.1.4 MnM view 203 13.1.1.4.1 Right to win 203 13.1.1.4.2 Strategic choices 203 13.1.1.4.3 Weaknesses & competitive threats 203   13.1.2 MEDTRONIC 204 13.1.2.1 Business overview 204 13.1.2.2 Products offered 206 13.1.2.3 MnM view 206 13.1.2.3.1 Right to win 206 13.1.2.3.2 Strategic choices 206 13.1.2.3.3 Weaknesses & competitive threats 207 13.1.3 TERUMO CORPORATION 208 13.1.3.1 Business overview 208 13.1.3.2 Products offered 210 13.1.3.3 Recent developments 210 13.1.3.3.1 Deals 210 13.1.3.3.2 Expansions 211 13.1.3.4 MnM view 211 13.1.3.4.1 Right to win 211 13.1.3.4.2 Strategic choices 211 13.1.3.4.3 Weaknesses & competitive threats 211 13.1.4 FRESENIUS MEDICAL CARE AG 212 13.1.4.1 Business overview 212 13.1.4.2 Products offered 213 13.1.4.3 Recent developments 214 13.1.4.3.1 Deals 214 13.1.4.4 MnM view 214 13.1.4.4.1 Right to win 214 13.1.4.4.2 Strategic choices 214 13.1.4.4.3 Weaknesses & competitive threats 214 13.1.5 LIVANOVA PLC 215 13.1.5.1 Business overview 215 13.1.5.2 Products offered 217 13.1.5.3 MnM view 217 13.1.5.3.1 Right to win 217 13.1.5.3.2 Strategic choices 217 13.1.5.3.3 Weaknesses & competitive threats 218 13.1.6 NIPRO 219 13.1.6.1 Business overview 219 13.1.6.2 Products offered 220 13.1.7 WEIGAO GROUP CO., LTD. 221 13.1.7.1 Business overview 221 13.1.7.2 Products offered 223 13.1.8 ABBOTT 224 13.1.8.1 Business overview 224 13.1.8.2 Products offered 225 13.1.8.3 Recent developments 226 13.1.8.3.1 Product approvals 226 13.1.9 MICROPORT SCIENTIFIC CORPORATION 227 13.1.9.1 Business overview 227 13.1.9.2 Products offered 228 13.1.10 EUROSETS 229 13.1.10.1 Business overview 229 13.1.10.2 Products offered 229 13.2 OTHER PLAYERS 230 13.2.1 SPECTRUM MEDICAL 230 13.2.2 SENKO MEDICAL INSTRUMENT MFG. CO., LTD. 231 13.2.3 CHALICE MEDICAL LTD. 232 13.2.4 MAGASSIST CO., LTD. 233 13.2.5 BRAILE BIOMÉDICA 234 13.2.6 GIZMOMED PRIVATE LIMITED 235 13.2.7 ORIGEN BIOMEDICAL, INC. 236 13.2.8 ABIOMED 236 13.2.9 ANDOCOR 237 13.2.10 JIANGSU STMED TECHNOLOGY CO., LTD. 238 13.2.11 CARDIOQUIP 238 13.2.12 CBM LIFEMOTION 239 13.2.13 CHANGZHOU KANGXIN MEDICAL INSTRUMENTS 240 13.2.14 GENTHERM 241 14 APPENDIX 242 14.1 DISCUSSION GUIDE 242 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 248 14.3 CUSTOMIZATION OPTIONS 250 14.4 RELATED REPORTS 250 14.5 AUTHOR DETAILS 251
圖表清單 List of Tables & Figures
TABLE 1 ECMO MACHINES MARKET: INCLUSIONS AND EXCLUSIONS 27 TABLE 2 STANDARD CURRENCY CONVERSION RATES, 2020–2024 28 TABLE 3 ECMO MACHINES MARKET: RISK ASSESSMENT 44 TABLE 4 ECMO MACHINES MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS 54 TABLE 5 AVERAGE COST OF ECMO, BY COUNTRY, 2024 (USD) 56 TABLE 6 AVERAGE SELLING PRICE OF KEY PLAYERS, BY TYPE, 2024 (USD) 58 TABLE 7 AVERAGE SELLING PRICE TREND OF ECMO MACHINES, BY REGION, 2022–2024 (USD) 59 TABLE 8 ECMO MACHINES MARKET: ROLE OF COMPANIES IN ECOSYSTEM 64 TABLE 9 IMPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD THOUSAND) 71 TABLE 10 EXPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD THOUSAND) 72 TABLE 11 ECMO MACHINES MARKET: KEY CONFERENCES AND EVENTS, 2025–2026 73 TABLE 12 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79 TABLE 13 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79 TABLE 14 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80 TABLE 15 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80 TABLE 16 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80 TABLE 17 ECMO MACHINES MARKET: PORTER’S FIVE FORCES ANALYSIS 82 TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP TWO PRODUCTS (%) 84 TABLE 19 KEY BUYING CRITERIA FOR TOP TWO PRODUCTS 84 TABLE 20 US-ADJUSTED RECIPROCAL TARIFF RATES 89 TABLE 21 KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR ECMO MACHINES 89 TABLE 22 ECMO MACHINES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 93 TABLE 23 COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 93 TABLE 24 COMPONENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 94 TABLE 25 EXAMPLES OF OXYGENATORS 95 TABLE 26 OXYGENATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 95 TABLE 27 EXAMPLES OF PUMPS 96 TABLE 28 PUMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 96 TABLE 29 EXAMPLES OF CONTROLLERS 97 TABLE 30 CONTROLLERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 97 TABLE 31 EXAMPLES OF CANNULAS 98 TABLE 32 CANNULAS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 99 TABLE 33 EXAMPLES OF ACCESSORIES 100 TABLE 34 ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 100 TABLE 35 EXAMPLES OF MACHINES 101 TABLE 36 MACHINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 102 TABLE 37 MACHINES MARKET, BY REGION, 2023–2030 (UNITS) 102 TABLE 38 ECMO MACHINES MARKET, BY MODALITY, 2023–2030 (USD MILLION) 104 TABLE 39 VENOVENOUS ECMO MACHINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 105 TABLE 40 VENOARTERIAL ECMO MACHINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 106 TABLE 41 ARTERIOVENOUS ECMO MACHINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 107 TABLE 42 COMMON INDICATIONS FOR ECMO IN NEONATES, PEDIATRIC PATIENTS, AND ADULT PATIENTS 109 TABLE 43 ECMO MACHINES MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 109 TABLE 44 ECMO MACHINES MARKET FOR ADULT PATIENTS, BY COUNTRY, 2023–2030 (USD MILLION) 110 TABLE 45 ECMO MACHINES MARKET FOR PEDIATRIC PATIENTS, BY COUNTRY, 2023–2030 (USD MILLION) 111 TABLE 46 ECMO MACHINES MARKET FOR NEONATES, BY COUNTRY, 2023–2030 (USD MILLION) 112 TABLE 47 ECMO MACHINES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 114 TABLE 48 ECMO MACHINES MARKET FOR RESPIRATORY APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 115 TABLE 49 ECMO MACHINES MARKET FOR CARDIAC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 116 TABLE 50 ECMO MACHINES MARKET FOR EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION, BY COUNTRY, 2023–2030 (USD MILLION) 117 TABLE 51 ECMO MACHINES MARKET, BY END USER, 2023–2030 (USD MILLION) 119 TABLE 52 ECMO MACHINES MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION) 120 TABLE 53 ECMO MACHINES MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2023–2030 (USD MILLION) 121 TABLE 54 ECMO MACHINES MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 122 TABLE 55 ECMO MACHINES MARKET, BY REGION, 2023–2030 (USD MILLION) 124 TABLE 56 NORTH AMERICA: ECMO MACHINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 125 TABLE 57 NORTH AMERICA: ECMO MACHINES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 126 TABLE 58 NORTH AMERICA: COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 126 TABLE 59 NORTH AMERICA: ECMO MACHINES MARKET, BY MODALITY, 2023–2030 (USD MILLION) 126 TABLE 60 NORTH AMERICA: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 127 TABLE 61 NORTH AMERICA: ECMO MACHINES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 127 TABLE 62 NORTH AMERICA: ECMO MACHINES MARKET, BY END USER, 2023–2030 (USD MILLION) 127 TABLE 63 US: MACROECONOMIC INDICATORS 128 TABLE 64 US: ECMO MACHINES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 128 TABLE 65 US: COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 129 TABLE 66 US: ECMO MACHINES MARKET, BY MODALITY, 2023–2030 (USD MILLION) 129 TABLE 67 US: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 129 TABLE 68 US: ECMO MACHINES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 130 TABLE 69 US: ECMO MACHINES MARKET, BY END USER, 2023–2030 (USD MILLION) 130 TABLE 70 CANADA: MACROECONOMIC INDICATORS 131 TABLE 71 CANADA: ECMO MACHINES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 131 TABLE 72 CANADA: COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 131 TABLE 73 CANADA: ECMO MACHINES MARKET, BY MODALITY, 2023–2030 (USD MILLION) 131 TABLE 74 CANADA: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 132 TABLE 75 CANADA: ECMO MACHINES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 132 TABLE 76 CANADA: ECMO MACHINES MARKET, BY END USER, 2023–2030 (USD MILLION) 132 TABLE 77 EUROPE: ECMO MACHINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 133 TABLE 78 EUROPE: ECMO MACHINES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 134 TABLE 79 EUROPE: COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 134 TABLE 80 EUROPE: ECMO MACHINES MARKET, BY MODALITY, 2023–2030 (USD MILLION) 134 TABLE 81 EUROPE: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 134 TABLE 82 EUROPE: ECMO MACHINES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 135 TABLE 83 EUROPE: ECMO MACHINES MARKET, BY END USER, 2023–2030 (USD MILLION) 135 TABLE 84 GERMANY: MACROECONOMIC INDICATORS 136 TABLE 85 GERMANY: ECMO MACHINES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 136 TABLE 86 GERMANY: COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 136 TABLE 87 GERMANY: ECMO MACHINES MARKET, BY MODALITY, 2023–2030 (USD MILLION) 137 TABLE 88 GERMANY: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 137 TABLE 89 GERMANY: ECMO MACHINES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 137 TABLE 90 GERMANY: ECMO MACHINES MARKET, BY END USER, 2023–2030 (USD MILLION) 138 TABLE 91 FRANCE: MACROECONOMIC INDICATORS 138 TABLE 92 FRANCE: ECMO MACHINES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 138 TABLE 93 FRANCE: COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 139 TABLE 94 FRANCE: ECMO MACHINES MARKET, BY MODALITY, 2023–2030 (USD MILLION) 139 TABLE 95 FRANCE: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 139 TABLE 96 FRANCE: ECMO MACHINES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 140 TABLE 97 FRANCE: ECMO MACHINES MARKET, BY END USER, 2023–2030 (USD MILLION) 140 TABLE 98 UK: MACROECONOMIC INDICATORS 141 TABLE 99 UK: ECMO MACHINES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 141 TABLE 100 UK: COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 141 TABLE 101 UK: ECMO MACHINES MARKET, BY MODALITY, 2023–2030 (USD MILLION) 141 TABLE 102 UK: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 142 TABLE 103 UK: ECMO MACHINES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 142 TABLE 104 UK: ECMO MACHINES MARKET, BY END USER, 2023–2030 (USD MILLION) 142 TABLE 105 ITALY: MACROECONOMIC INDICATORS 143 TABLE 106 ITALY: ECMO MACHINES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 143 TABLE 107 ITALY: COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 144 TABLE 108 ITALY: ECMO MACHINES MARKET, BY MODALITY, 2023–2030 (USD MILLION) 144 TABLE 109 ITALY: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 144 TABLE 110 ITALY: ECMO MACHINES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 145 TABLE 111 ITALY: ECMO MACHINES MARKET, BY END USER, 2023–2030 (USD MILLION) 145 TABLE 112 SPAIN: MACROECONOMIC INDICATORS 146 TABLE 113 SPAIN: ECMO MACHINES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 146 TABLE 114 SPAIN: COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 146 TABLE 115 SPAIN: ECMO MACHINES MARKET, BY MODALITY, 2023–2030 (USD MILLION) 146 TABLE 116 SPAIN: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 147 TABLE 117 SPAIN: ECMO MACHINES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 147 TABLE 118 SPAIN: ECMO MACHINES MARKET, BY END USER, 2023–2030 (USD MILLION) 147 TABLE 119 REST OF EUROPE: ECMO MACHINES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 148 TABLE 120 REST OF EUROPE: COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 148 TABLE 121 REST OF EUROPE: ECMO MACHINES MARKET, BY MODALITY, 2023–2030 (USD MILLION) 148 TABLE 122 REST OF EUROPE: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 149 TABLE 123 REST OF EUROPE: ECMO MACHINES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 149 TABLE 124 REST OF EUROPE: ECMO MACHINES MARKET, BY END USER, 2023–2030 (USD MILLION) 149 TABLE 125 ASIA PACIFIC: ECMO MACHINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 151 TABLE 126 ASIA PACIFIC: ECMO MACHINES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 151 TABLE 127 ASIA PACIFIC: COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 151 TABLE 128 ASIA PACIFIC: ECMO MACHINES MARKET, BY MODALITY, 2023–2030 (USD MILLION) 152 TABLE 129 ASIA PACIFIC: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 152 TABLE 130 ASIA PACIFIC: ECMO MACHINES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 152 TABLE 131 ASIA PACIFIC: ECMO MACHINES MARKET, BY END USER, 2023–2030 (USD MILLION) 153 TABLE 132 JAPAN: MACROECONOMIC INDICATORS 153 TABLE 133 JAPAN: ECMO MACHINES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 154 TABLE 134 JAPAN: COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 154 TABLE 135 JAPAN: ECMO MACHINES MARKET, BY MODALITY, 2023–2030 (USD MILLION) 154 TABLE 136 JAPAN: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 155 TABLE 137 JAPAN: ECMO MACHINES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 155 TABLE 138 JAPAN: ECMO MACHINES MARKET, BY END USER, 2023–2030 (USD MILLION) 155 TABLE 139 CHINA: MACROECONOMIC INDICATORS 156 TABLE 140 CHINA: ECMO MACHINES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 156 TABLE 141 CHINA: COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 157 TABLE 142 CHINA: ECMO MACHINES MARKET, BY MODALITY, 2023–2030 (USD MILLION) 157 TABLE 143 CHINA: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 157 TABLE 144 CHINA: ECMO MACHINES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 158 TABLE 145 CHINA: ECMO MACHINES MARKET, BY END USER, 2023–2030 (USD MILLION) 158 TABLE 146 INDIA: MACROECONOMIC INDICATORS 158 TABLE 147 INDIA: ECMO MACHINES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 159 TABLE 148 INDIA: COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 159 TABLE 149 INDIA: ECMO MACHINES MARKET, BY MODALITY, 2023–2030 (USD MILLION) 159 TABLE 150 INDIA: ECMO MACHINES MARKET, PATIENT TYPE, 2023–2030 (USD MILLION) 160 TABLE 151 INDIA: ECMO MACHINES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 160 TABLE 152 INDIA: ECMO MACHINES MARKET, BY END USER, 2023–2030 (USD MILLION) 160 TABLE 153 SOUTH KOREA: MACROECONOMIC INDICATORS 161 TABLE 154 SOUTH KOREA: ECMO MACHINES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 161 TABLE 155 SOUTH KOREA: COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 162 TABLE 156 SOUTH KOREA: ECMO MACHINES MARKET, BY MODALITY, 2023–2030 (USD MILLION) 162 TABLE 157 SOUTH KOREA: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 162 TABLE 158 SOUTH KOREA: ECMO MACHINES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 163 TABLE 159 SOUTH KOREA: ECMO MACHINES MARKET, BY END USER, 2023–2030 (USD MILLION) 163 TABLE 160 AUSTRALIA: MACROECONOMIC INDICATORS 164 TABLE 161 AUSTRALIA: ECMO MACHINES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 164 TABLE 162 AUSTRALIA: COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 164 TABLE 163 AUSTRALIA: ECMO MACHINES MARKET, BY MODALITY, 2023–2030 (USD MILLION) 164 TABLE 164 AUSTRALIA: ECMO MACHINES MARKET, PATIENT TYPE, 2023–2030 (USD MILLION) 165 TABLE 165 AUSTRALIA: ECMO MACHINES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 165 TABLE 166 AUSTRALIA: ECMO MACHINES MARKET, BY END USER, 2023–2030 (USD MILLION) 165 TABLE 167 REST OF ASIA PACIFIC: ECMO MACHINES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 166 TABLE 168 REST OF ASIA PACIFIC: COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 166 TABLE 169 REST OF ASIA PACIFIC: ECMO MACHINES MARKET, BY MODALITY, 2023–2030 (USD MILLION) 166 TABLE 170 REST OF ASIA PACIFIC: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 167 TABLE 171 REST OF ASIA PACIFIC: ECMO MACHINES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 167 TABLE 172 REST OF ASIA PACIFIC: ECMO MACHINES MARKET, BY END USER, 2023–2030 (USD MILLION) 167 TABLE 173 LATIN AMERICA: ECMO MACHINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 168 TABLE 174 LATIN AMERICA: ECMO MACHINES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 169 TABLE 175 LATIN AMERICA: COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 169 TABLE 176 LATIN AMERICA: ECMO MACHINES MARKET, BY MODALITY, 2023–2030 (USD MILLION) 169 TABLE 177 LATIN AMERICA: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 170 TABLE 178 LATIN AMERICA: ECMO MACHINES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 170 TABLE 179 LATIN AMERICA: ECMO MACHINES MARKET, BY END USER, 2023–2030 (USD MILLION) 170 TABLE 180 BRAZIL: MACROECONOMIC INDICATORS 171 TABLE 181 BRAZIL: ECMO MACHINES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 171 TABLE 182 BRAZIL: COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 172 TABLE 183 BRAZIL: ECMO MACHINES MARKET, BY MODALITY, 2023–2030 (USD MILLION) 172 TABLE 184 BRAZIL: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 172 TABLE 185 BRAZIL: ECMO MACHINES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 173 TABLE 186 BRAZIL: ECMO MACHINES MARKET, BY END USER, 2023–2030 (USD MILLION) 173 TABLE 187 MEXICO: MACROECONOMIC INDICATORS 174 TABLE 188 MEXICO: ECMO MACHINES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 174 TABLE 189 MEXICO: COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 174 TABLE 190 MEXICO: ECMO MACHINES MARKET, BY MODALITY, 2023–2030 (USD MILLION) 174 TABLE 191 MEXICO: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 175 TABLE 192 MEXICO: ECMO MACHINES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 175 TABLE 193 MEXICO: ECMO MACHINES MARKET, BY END USER, 2023–2030 (USD MILLION) 175 TABLE 194 REST OF LATIN AMERICA: ECMO MACHINES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 176 TABLE 195 REST OF LATIN AMERICA: COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 176 TABLE 196 REST OF LATIN AMERICA: ECMO MACHINES MARKET, BY MODALITY, 2023–2030 (USD MILLION) 176 TABLE 197 REST OF LATIN AMERICA: ECMO MACHINES MARKET, PATIENT TYPE, 2023–2030 (USD MILLION) 177 TABLE 198 REST OF LATIN AMERICA: ECMO MACHINES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 177 TABLE 199 REST OF LATIN AMERICA: ECMO MACHINES MARKET, BY END USER, 2023–2030 (USD MILLION) 177 TABLE 200 MIDDLE EAST & AFRICA: ECMO MACHINES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 178 TABLE 201 MIDDLE EAST & AFRICA: COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 179 TABLE 202 MIDDLE EAST & AFRICA: ECMO MACHINES MARKET, BY MODALITY, 2023–2030 (USD MILLION) 179 TABLE 203 MIDDLE EAST & AFRICA: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 179 TABLE 204 MIDDLE EAST & AFRICA: ECMO MACHINES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 180 TABLE 205 MIDDLE EAST & AFRICA: ECMO MACHINES MARKET, BY END USER, 2023–2030 (USD MILLION) 180 TABLE 206 GCC COUNTRIES: ECMO MACHINES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 181 TABLE 207 GCC COUNTRIES: COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 181 TABLE 208 GCC COUNTRIES: ECMO MACHINES MARKET, BY MODALITY, 2023–2030 (USD MILLION) 182 TABLE 209 GCC COUNTRIES: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 182 TABLE 210 GCC COUNTRIES: ECMO MACHINES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 182 TABLE 211 GCC COUNTRIES: ECMO MACHINES MARKET, BY END USER, 2023–2030 (USD MILLION) 183 TABLE 212 KEY DEVELOPMENTS IN ECMO MACHINES MARKET, JANUARY 2021–SEPTEMBER 2025 184 TABLE 213 ECMO MACHINES MARKET: DEGREE OF COMPETITION 187 TABLE 214 ECMO MACHINES MARKET: REGION FOOTPRINT 191 TABLE 215 ECMO MACHINES MARKET: PRODUCT FOOTPRINT 191 TABLE 216 ECMO MACHINES MARKET: APPLICATION FOOTPRINT 192 TABLE 217 ECMO MACHINES MARKET: END-USER FOOTPRINT 192 TABLE 218 ECMO MACHINES MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS 195 TABLE 219 ECMO MACHINES MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS, BY REGION AND APPLICATION 195 TABLE 220 ECMO MACHINES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–SEPTEMBER 2025 198 TABLE 221 ECMO MACHINES MARKET: DEALS, JANUARY 2021–SEPTEMBER 2025 199 TABLE 222 ECMO MACHINES MARKET: EXPANSIONS, JANUARY 2021–SEPTEMBER 2025 199 TABLE 223 GETINGE: COMPANY OVERVIEW 200 TABLE 224 GETINGE: PRODUCTS OFFERED 201 TABLE 225 GETINGE: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2025 202 TABLE 226 GETINGE: EXPANSIONS, JANUARY 2021–SEPTEMBER 2025 202 TABLE 227 MEDTRONIC: COMPANY OVERVIEW 204 TABLE 228 MEDTRONIC: PRODUCTS OFFERED 206 TABLE 229 TERUMO CORPORATION: COMPANY OVERVIEW 208 TABLE 230 TERUMO CORPORATION: PRODUCTS OFFERED 210 TABLE 231 TERUMO CORPORATION: DEALS, JANUARY 2021–SEPTEMBER 2025 210 TABLE 232 TERUMO CORPORATION: EXPANSIONS, JANUARY 2021–SEPTEMBER 2025 211 TABLE 233 FRESENIUS MEDICAL CARE AG: COMPANY OVERVIEW 212 TABLE 234 FRESENIUS MEDICAL CARE AG: PRODUCTS OFFERED 213 TABLE 235 FRESENIUS MEDICAL CARE AG: DEALS, JANUARY 2021–SEPTEMBER 2025 214 TABLE 236 LIVANOVA PLC: COMPANY OVERVIEW 215 TABLE 237 LIVANOVA PLC: PRODUCTS OFFERED 217 TABLE 238 NIPRO: COMPANY OVERVIEW 219 TABLE 239 NIPRO: PRODUCTS OFFERED 220 TABLE 240 WEIGAO GROUP CO., LTD.: COMPANY OVERVIEW 221 TABLE 241 WEIGAO GROUP CO., LTD.: PRODUCTS OFFERED 223 TABLE 242 ABBOTT: COMPANY OVERVIEW 224 TABLE 243 ABBOTT: PRODUCTS OFFERED 225 TABLE 244 ABBOTT: PRODUCT APPROVALS, JANUARY 2021–SEPTEMBER 2025 226 TABLE 245 MICROPORT SCIENTIFIC CORPORATION: COMPANY OVERVIEW 227 TABLE 246 MICROPORT SCIENTIFIC CORPORATION: PRODUCTS OFFERED 228 TABLE 247 EUROSETS: COMPANY OVERVIEW 229 TABLE 248 EUROSETS: PRODUCTS OFFERED 229 TABLE 249 SPECTRUM MEDICAL: COMPANY OVERVIEW 230 TABLE 250 SENKO MEDICAL INSTRUMENT MFG. CO., LTD.: COMPANY OVERVIEW 231 TABLE 251 CHALICE MEDICAL LTD.: COMPANY OVERVIEW 232 TABLE 252 MAGASSIST CO., LTD.: COMPANY OVERVIEW 233 TABLE 253 BRAILE BIOMÉDICA: COMPANY OVERVIEW 234 TABLE 254 GIZMOMED PRIVATE LIMITED: COMPANY OVERVIEW 235 TABLE 255 ORIGEN BIOMEDICAL, INC.: COMPANY OVERVIEW 236 TABLE 256 ABIOMED: COMPANY OVERVIEW 236 TABLE 257 ANDOCOR: COMPANY OVERVIEW 237 TABLE 258 JIANGSU STMED TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 238 TABLE 259 CARDIOQUIP: COMPANY OVERVIEW 238 TABLE 260 CBM LIFEMOTION: COMPANY OVERVIEW 239 TABLE 261 CHANGZHOU KANGXIN MEDICAL INSTRUMENTS: COMPANY OVERVIEW 240 TABLE 262 GENTHERM: COMPANY OVERVIEW 241 FIGURE 1 ECMO MACHINES MARKET SEGMENTATION AND REGIONAL SCOPE 26 FIGURE 2 ECMO MACHINES MARKET: RESEARCH DESIGN 31 FIGURE 3 PRIMARY SOURCES 33 FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 35 FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY-SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 36 FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND-SIDE): BY END USER, DESIGNATION, AND REGION 36 FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 37 FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION OF GETINGE AB, 2024 38 FIGURE 9 ECMO MACHINES MARKET: SUPPLY-SIDE MARKET SIZE ESTIMATION, 2024 39 FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DYNAMICS, 2025–2030 40 FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 41 FIGURE 12 ECMO MACHINES MARKET: TOP-DOWN APPROACH 41 FIGURE 13 DATA TRIANGULATION METHODOLOGY 43 FIGURE 14 ECMO MACHINES MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION) 45 FIGURE 15 ECMO MACHINES MARKET, BY MODALITY, 2025 VS. 2030 (USD MILLION) 46 FIGURE 16 ECMO MACHINES MARKET, BY PATIENT TYPE, 2025 VS. 2030 (USD MILLION) 46 FIGURE 17 ECMO MACHINES MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 47 FIGURE 18 ECMO MACHINES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 47 FIGURE 19 GEOGRAPHICAL SNAPSHOT OF ECMO MACHINES MARKET 48 FIGURE 20 GROWING DEMAND FOR INTEGRATED MULTIFUNCTIONAL DEVICES AND EXPANDING ACCESS TO ADVANCED ICUS IN UNDERSERVED REGIONS TO DRIVE MARKET GROWTH 49 FIGURE 21 COMPONENTS SEGMENT TO ACCOUNT FOR LARGEST SHARE OF APAC MARKET IN 2024 50 FIGURE 22 INDIA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 51 FIGURE 23 NORTH AMERICA TO DOMINATE ECMO MACHINES MARKET 51 FIGURE 24 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD 52 FIGURE 25 ECMO MACHINES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 53 FIGURE 26 ECMO MACHINES MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 58 FIGURE 27 AVERAGE SELLING PRICE TREND OF ECMO MACHINES, BY REGION, 2022–2024 (USD) 59 FIGURE 28 VALUE CHAIN ANALYSIS: MAJOR VALUE-ADDED DURING MANUFACTURING AND DISTRIBUTION PHASES 60 FIGURE 29 ECMO MACHINES MARKET: SUPPLY CHAIN ANALYSIS 63 FIGURE 30 ECMO MACHINES MARKET: ECOSYSTEM ANALYSIS 63 FIGURE 31 ECMO MACHINES MARKET: INVESTMENT AND FUNDING SCENARIO, 2019–2023 65 FIGURE 32 ECMO MACHINES MARKET: VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 65 FIGURE 33 ECMO MACHINES MARKET: NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 (USD MILLION) 66 FIGURE 34 ECMO MACHINES MARKET: PATENT ANALYSIS, JANUARY 2015−JULY 2025 70 FIGURE 35 ECMO MACHINES MARKET: PORTER’S FIVE FORCES ANALYSIS 81 FIGURE 36 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP TWO PRODUCTS 83 FIGURE 37 KEY BUYING CRITERIA FOR TOP TWO PRODUCTS 84 FIGURE 38 NORTH AMERICA: ECMO MACHINES MARKET SNAPSHOT 125 FIGURE 39 ASIA PACIFIC: ECMO MACHINES MARKET SNAPSHOT 150 FIGURE 40 REVENUE ANALYSIS OF KEY PLAYERS IN ECMO MACHINES MARKET, 2020–2024 (USD MILLION) 186 FIGURE 41 MARKET SHARE ANALYSIS OF KEY PLAYERS IN ECMO MACHINES MARKET (2024) 187 FIGURE 42 ECMO MACHINES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 189 FIGURE 43 ECMO MACHINES MARKET: COMPANY FOOTPRINT 190 FIGURE 44 ECMO MACHINES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 194 FIGURE 45 EV/EBITDA OF KEY VENDORS 196 FIGURE 46 YEAR-TO-DATE (YTD) PRICE, TOTAL RETURN, AND 5-YEAR STOCK BETA OF KEY VENDORS 196 FIGURE 47 ECMO MACHINES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 197 FIGURE 48 GETINGE: COMPANY SNAPSHOT 201 FIGURE 49 MEDTRONIC: COMPANY SNAPSHOT 205 FIGURE 50 TERUMO CORPORATION: COMPANY SNAPSHOT 209 FIGURE 51 FRESENIUS MEDICAL CARE AG: COMPANY SNAPSHOT 213 FIGURE 52 LIVANOVA PLC: COMPANY SNAPSHOT 216 FIGURE 53 NIPRO: COMPANY SNAPSHOT 220 FIGURE 54 WEIGAO GROUP CO., LTD.: COMPANY SNAPSHOT 222 FIGURE 55 ABBOTT: COMPANY SNAPSHOT 225 FIGURE 56 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT 228

同分類最新報告（醫療器材）

查看醫療器材全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們